Abstract
The neurobiology drug discovery landscape has transformed over the past decade or so by the discovery of allosteric modulators of receptor superfamilies. A wide range of physiological reactions are able to occur in response to a limited number of neurotransmitters. In this chapter, we will describe the general features of the receptors and the signaling pathways that are generated in response to neuroreceptor activation that allow for the explanation of this vast array of neurotransmitter responses. Primarily based upon structure, receptors in the nervous system can be classified into four groups: ligand-gated receptors, G-protein coupled receptors, enzyme-linked receptors, and nuclear receptors. We identify the neuroreceptors, their endogenous agonists, antagonists, sites of expression within the nervous system, and neuropharmacological clinical use. New molecular approaches and advances in our understanding of receptor biology combined with opportunities to repurpose existing drugs for new indications continue to highlight the exciting opportunities for modulating neuroreceptors for therapeutic purposes.
Corpora non agunt nisi fixate
Compounds do not act unless bound
—Paul Ehrlich, 1908 Nobel Prize in Medicine
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- 12(R)-HPETE:
-
12R-hydroperoxyeicosatetraenoic acid
- 4-TM:
-
Four transmembrane-spanning α-helices
- 5-HT:
-
5-Hydroxytryptamine
- 7-TM:
-
Seven transmembrane-spanning α-helices
- A1:
-
Adenosine A1 receptor
- A2A:
-
Adenosine 2A receptor
- A2B:
-
Adenosine 2B receptor
- A3:
-
Adenosine 3 receptor
- ACh:
-
Acetylcholine
- AChBP:
-
Acetylcholine-binding protein
- ACKR:
-
Atypical chemokine receptor
- ACTH:
-
Adrenocorticotropic hormone
- ADAR:
-
RNA-specific adenosine deaminase
- ADGR:
-
Adhesion G protein-coupled receptor
- ADP:
-
Adenosine diphosphate
- AF-1:
-
Activation function-1
- AM:
-
Adrenomedullin
- AMP:
-
Adenosine monophosphate
- AMPA:
-
α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
- AMY:
-
Amylin
- AN:
-
Arcuate
- ANF:
-
Atrial natriuretic factor
- ANGPT:
-
Angiopoietin
- ANP:
-
Atrial natriuretic peptide
- AR:
-
Androgen receptor
- ASIC:
-
Acid-sensing ion channel
- AT2:
-
Angiotensin II receptor type 2
- AXL:
-
AXL receptor tyrosine kinase
- BAI:
-
Brain-specific angiogenesis inhibitor
- BB:
-
Bombesin BB receptor
- BDNF:
-
Brain-derived neurotrophic factor
- BLT:
-
Leukotriene B4 receptor
- C3a:
-
Complement peptide receptor C3a
- CAH:
-
Carbonic anhydrase
- CAK:
-
CDC-activating kinase
- CAKAK:
-
CAK-activating kinase
- CaMK:
-
Calcium/calmodulin-dependent protein kinase
- cAMP:
-
Cyclic adenosine monophosphate
- CAR:
-
Constitutive androstane receptor
- CAS:
-
Ca2+-Sensing
- CASK:
-
Calcium/calmodulin-dependent serin protein kinase
- CaV:
-
Voltage-gated calcium channel
- CB:
-
Cannabinoid receptor
- CCK:
-
Cholecystokinin
- CCL:
-
C-C chemokine ligand
- CCR:
-
C-C chemokine receptor
- CD:
-
Cluster of differentiation
- CDK:
-
Cyclin-dependent kinase
- CELSR:
-
Cadherin EGF LAG seven-pass G-type receptor
- cGMP:
-
Cyclic guanosine monophosphate
- CGRP:
-
Calcitonin gene-related peptide
- CLR:
-
C-type lectin receptor
- CNS:
-
Central nervous system
- CO:
-
Colliculi
- COL3A1:
-
Collagen type III alpha 1 chain
- COUP-TF:
-
Chicken ovalbumin upstream promoter-transcription factor
- CP:
-
Caudate Putamen
- CRF:
-
Corticotropin-releasing factor receptor type
- CSF1R:
-
Colony stimulating factor 1 receptor
- CT:
-
Calcitonin
- CTP:
-
Cytidine triphosphate
- CX3CL:
-
C-X3-C chemokine ligand
- CX3CR:
-
C-X3-C chemokine receptor
- CXCL:
-
Chemokine (C-X-C motif) ligand
- CXCR:
-
Chemokine (C-X-C) motif receptor
- Cys:
-
Cysteine
- D:
-
Dopamine receptor D
- DAG:
-
Diacylglycerol
- DAX-1:
-
Dosage-sensitive sex reversal adrenal hypoplasia congenital critical region on the X chromosome, gene1
- DBD:
-
DNA binding domain
- DDR:
-
Discoidin domain receptor
- DP:
-
Prostaglandin D2 receptor
- DRD:
-
Dopamine receptors
- ECD:
-
Extracellular domain
- EGF:
-
Epidermal growth factor
- EGFR:
-
Epidermal growth factor receptor
- EMR1:
-
EGF-like module-containing mucin-like hormone receptor-like 1 (also known as F4/80)
- ENaC:
-
Epithelial sodium channel
- EP:
-
Prostaglandin E2 receptor
- Eph:
-
Erythropoietin-producing
- Ephrin:
-
Eph receptor-interacting ligand
- ErbB4:
-
Erb-B2 receptor tyrosine kinase 4
- ERK:
-
Extracellular signal-regulated kinase
- ERK:
-
Extracellular signal-regulated protein kinase
- ERR:
-
Estrogen-related receptor
- ESRRG:
-
Estrogen-related Receptor γ
- ET:
-
Endothelin receptor type
- F2L:
-
Formylpeptide receptor (FPR)-like (FPRL)-2 ligand
- FGF:
-
Fibroblast growth factor
- FGFR:
-
Fibroblast growth factor receptor
- FLT3:
-
FMS-like tyrosine kinase 3
- FLT3L:
-
FMS-like tyrosine kinase 3 ligand
- FN:
-
Fibronectin
- FN-III:
-
Fibronectin type III domain
- FP:
-
Prostaglandin F receptor
- FPR:
-
Formyl peptide receptor
- FSH:
-
Follicle stimulating hormone receptor
- FXR:
-
Farnesoid X receptor
- FZD:
-
Frizzled
- GABA:
-
Gamma-aminobutyric acid
- GABAA:
-
Gamma-aminobutyric acid A receptor
- GABAB:
-
Gamma-aminobutyric acid B receptor
- GABP:
-
GA-binding protein
- GAL:
-
Galanin
- GAL:
-
Galanin receptor
- GC:
-
Guanylate cyclase
- GCNF:
-
Germ cell nuclear factor
- GHRH:
-
Growth hormone–releasing hormone
- GHRHR:
-
Growth hormone–releasing hormone receptor
- GIP:
-
Glucose-dependent insulinotropic polypeptide
- GIRK:
-
G protein-coupled inwardly-rectifying potassium channels
- GLEPP:
-
Glomerular epithelial protein
- GLP:
-
Glucagon-like peptide
- Glu:
-
Glutamate
- GluA:
-
Ca2+-permeable AMPA receptor
- GluK:
-
Kainate receptor
- GluN:
-
NMDA receptor
- GluR:
-
Glutamate receptor
- Gly:
-
Glycine
- GlyR:
-
Glycine receptor
- GlyT1:
-
Glycine transporter 1
- GlyT2:
-
Glycine transporter 2
- GnRH:
-
Gonadotropin-releasing hormone
- GPBA:
-
G protein-coupled bile acid
- GPCR:
-
G protein-coupled receptor
- GPER:
-
G protein-coupled estrogen receptor
- GR:
-
Glucocorticoid receptor
- GRK:
-
G protein receptor kinase
- GRP:
-
Gastrin-releasing peptide
- GTP:
-
Guanosine triphosphate
- Gα:
-
Gα Protein subunit
- Gαgustducin:
-
Gα Protein, gustducin subunit (taste specificity)
- Gαi:
-
Gα Protein, inhibitory subunit; adenylate cyclase inactivated, cAMP down
- Gαo:
-
Gα Protein, other subunit
- H:
-
Hippocampus
- H:
-
Histamine receptor H
- HAT:
-
Histone acetyltransferase
- HB-EGF:
-
Heparin-binding EGF-like growth factor
- HCA:
-
Hydroxycarboxylic acid receptor
- HCF:
-
Heregulin
- hCG:
-
Human chorionic gonadotropin
- HDAC:
-
Histone deacetylase
- HGF:
-
Hepatocyte growth factor
- HIV:
-
Human immunodeficiency virus
- HNF4:
-
Hepatic nuclear factor 4 receptor
- HR:
-
Hormone receptor
- HY:
-
Hypothalamus
- IA2:
-
Islet tyrosine phosphatase
- IGF:
-
Insulin-like growth factor
- iGlu:
-
Ionotropic glutamate
- iGluR:
-
Ionotropic glutamate receptor
- INaC:
-
Intestine sodium channel receptor
- IP:
-
Prostaglandin receptor
- IP3:
-
Inositol 1,4,5- trisphosphate
- IP3R:
-
Inositol 1,4,5-trisphosphate receptor
- JNK:
-
c-Jun amino-terminal kinase
- KIM:
-
Kinase interaction motif
- Kit:
-
Tyrosine protein kinase
- LAR:
-
Ligand-binding domain
- LBP:
-
Ligand-binding pocket
- LH:
-
Luteinizing hormone
- LL-37:
-
Antimicrobial peptide belonging to the cathelicidin family
- LMR:
-
Lemur kinase receptor subfamily
- LPA:
-
Lysophosphatidic acid receptor
- LRH-1:
-
Liver receptor homolog-1
- LTB:
-
Leukotriene
- LTK:
-
Leukocyte tyrosine kinase
- LTX:
-
α-Latrotoxin
- LXA4:
-
Lipoxin A4
- LXR:
-
Liver X receptor
- M:
-
Muscarinic acetylcholine receptor M
- mAChR:
-
Muscarinic acetylcholine receptor
- MAM:
-
Meprin-A5-μ domain
- MAP2K:
-
Mitogen-activated protein kinase
- MAPK:
-
Mitogen-activated protein kinase
- MC:
-
Melanocortin
- MCH:
-
Melanin-concentrating hormone receptor
- MEK:
-
Mitogen-activated protein kinase
- MER-TK:
-
Mer tyrosine kinase receptor
- Mg:
-
Magnesium
- mGlu:
-
Metabotropic glutamate
- mGluR:
-
Metabotropic glutamate receptor
- MR:
-
Mineralocorticoid receptor
- MSH:
-
Melanocyte stimulating hormone
- MT1:
-
Melatonin receptor type 1A
- MuSK:
-
Muscle-associated receptor tyrosine kinase
- Myt:
-
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase
- N/OFQ:
-
Nociceptin/orphanin Fq
- nAChR:
-
Nicotinic acetylcholine receptors
- NCOA1:
-
Nuclear receptor coactivator 1
- NCoR:
-
Nuclear receptor corepressor
- NF-κB:
-
Nuclear factor-κb
- NGF:
-
Nerve growth factor
- NK1:
-
Tachykinin receptor 1
- NMDA:
-
N-methyl-d-aspartate
- NMU1:
-
Neuromedin U receptor
- NO:
-
Nitric oxide
- NOP:
-
Nociception opioid peptide receptor
- NOR:
-
Neuron-derived orphan receptor
- NPBW:
-
Neuropeptide B/W receptor
- NPFF:
-
Neuropeptide FF receptor
- NPS:
-
Neuropeptide S
- NPY:
-
Neuropeptide Y
- NR0B:
-
Nuclear receptor subfamily 0 group B member
- Nrg:
-
Neuregulin
- NT:
-
Neurotrophin
- NTD:
-
N-terminal domain
- NTS:
-
Neurotensin receptor type
- NURR1:
-
Nurr-related receptor factor 1
- oGPCR:
-
Orphan G protein-coupled receptor
- OPN1LW:
-
Opsin 1, long wave sensitive
- OPN1MW:
-
Opsin 1, medium wave sensitive
- OPN1SW:
-
Opsin 1, short wave sensitive
- OX:
-
Orexin receptor type
- P2X:
-
Adenosine triphosphate–gated cation channel P2X purinoceptor
- P2Y:
-
G Protein-gated P2Y purinoceptor
- PAC:
-
Pituitary adenylate cyclase
- PAC1:
-
Pituitary adenylate cyclase–activating polypeptide-selective type I receptor
- PACAP:
-
Pituitary adenylate cyclase–activating polypeptide
- PAF:
-
Platelet-activating factor
- PAM:
-
Positive allosteric modulator
- PAR:
-
Protease-activated receptor
- PDGF:
-
Platelet-derived growth factor
- PDGFR:
-
Platelet-derived growth factor receptor
- PGR:
-
Progesterone receptor
- PHM:
-
Peptide histidine methionine
- PHV:
-
Peptide histidine valine
- PI3Kγ:
-
Phosphoinositide 3-kinase γ
- PKA:
-
Protein kinase A
- PKC:
-
Protein kinase C
- PKG:
-
Protein kinase G
- PKR1:
-
Prokineticin receptor 1
- PKR2:
-
Prokineticin receptor 2
- PLC-β:
-
Phospholipase C-β
- PNR :
-
Photoreceptor cell-specific nuclear receptor
- PP1:
-
Protein phosphatase 1
- PPAR:
-
Peroxisome proliferator-activated receptor
- PR:
-
Progesterone receptor
- PrP:
-
Prion protein
- PrRP:
-
Prolactin-releasing peptide
- PTEN :
-
Phosphatase and tensin homolog deleted on chromosome 10
- PTH:
-
Parathyroid hormone receptor
- PTHrP:
-
Parathyroid hormone–related protein
- PTK:
-
Protein tyrosine kinase
- PTP:
-
Protein tyrosine phosphatase
- PXR:
-
Pregnane X receptor
- PYY:
-
Peptide YY
- QRFP:
-
Neuropeptide 26RFa
- RACK:
-
Receptors for activated C kinase
- RAMP:
-
Receptor activity-modifying proteins
- RAPGEF3:
-
Rap guanine nucleotide exchange factor 3
- RAR:
-
Retinoic acid receptor
- RARα:
-
Retinoic acid receptor
- RDGS:
-
Peptides containing the sequence Arg-Gly-Asp-Ser
- RET:
-
Ret proto-oncogene
- REV-ERB:
-
Reverse-Erb receptor
- REV-ERBα:
-
Reverse-Erb-Α
- REV-ERBβ:
-
Reverse-Erb-Î’
- rGC:
-
Receptor guanylyl cyclase
- Rho:
-
Rho family of GTPases belong to the Ras superfamily of proteins
- RhoA:
-
Ras homolog family member, a Rho family GTPase
- RIP 140:
-
Receptor-interacting protein 140
- ROR:
-
Retinoic acid–related orphan receptor
- ROS:
-
Proto-oncogene that encodes an orphan receptor-type tyrosine kinase
- RPTP:
-
Receptor-like protein tyrosine phosphatase
- RSTK:
-
Receptor serine–threonine kinase
- RXFP:
-
Relaxin family peptide
- RXR:
-
Retinoid X receptor
- RYK:
-
Transmembrane receptor tyrosine kinase
- S1P:
-
Sphingosine-1-phosphate
- SAP:
-
SLAM-associated protein
- SAPK:
-
Stress-activated protein kinase
- SCAM:
-
Substituted cysteine accessibility method
- SCF:
-
Stem cell factor
- SEA:
-
Stearoylethanolamide
- SF-1:
-
Steroidogenic factor 1
- SFK:
-
Src family of protein tyrosine kinases
- SHH:
-
Sonic hedgehog
- SHP:
-
Small heterodimer partner
- SHP-2:
-
SH2 domain–containing protein tyrosine phosphatase-2
- SK3:
-
Glycogen synthase kinase 3
- SMO:
-
Smoothened
- SMRT:
-
Silencing mediator of retinoic acid thyroid hormone receptors
- SNARE:
-
Soluble-N-ethylmaleimide-sensitive-factor accessory-protein receptor
- SRC:
-
Steroid receptor coactivator
- SRIF:
-
Somatotropin release–inhibiting factor; also known as somatostatin
- SST:
-
Somatostatin receptor
- STEP:
-
Striatal-enriched phosphatase
- STYK1:
-
Serine/threonine/tyrosine kinase 1
- SUMO:
-
Small ubiquitin–related modifier
- TAM:
-
Typo3, Axl, and Mer family of tyrosine kinase receptors
- TAS1R:
-
Taste 1 Receptor
- TGF:
-
Transforming growth factor
- THRA:
-
Thyroid hormone receptor α
- THRB:
-
Thyroid hormone receptor β
- Tie:
-
Tyrosine kinase with immunoglobulin like and EGF-like domains
- TKAR:
-
Tyrosine kinase–associated receptors
- TLX:
-
The human orphan nuclear receptor tailless; also known as NR2E1
- TNF:
-
Tumor necrosis factor
- TP:
-
Thromboxane receptor
- TR:
-
Thyroid hormone receptor
- TRH:
-
Thyrotropin-releasing hormone
- TrK:
-
Tropomyosin receptor kinase
- TYRO3:
-
TAM family receptor tyrosine kinase
- Ucn:
-
Urocortin
- UDP:
-
Uridine diphosphate
- UT:
-
Urotensin
- UTP:
-
Uridine-5′-triphosphate
- VDR:
-
Vitamin D receptor
- VEGFR:
-
Vascular endothelial growth factor receptor
- VIP:
-
Vasoactive intestinal peptide
- VIPR:
-
Vasoactive intestinal peptide receptor
- VPAC:
-
Vasoactive intestinal polypeptide receptor
- Wnt:
-
Coined from the drosophila gene Wingless and the mouse oncogene Int-1.
- WNT:
-
Superfamily of Wnt signaling proteins
- Y:
-
Neuropeptide Y receptor
- ZAC:
-
Zinc-activated channel receptor
- Zn:
-
Zinc
- α12A:
-
Adrenoreceptor type α2A
- α12AB:
-
Adrenoreceptor type α2B
- α12AC:
-
Adrenoreceptor type α2C
- α1A:
-
Adrenoreceptor type α1A
- α1B:
-
Adrenoreceptor type α1B
- α1D:
-
Adrenoreceptor type α1D
- β:
-
β-adrenergic receptor
- βARK:
-
β-adrenergic receptor kinase
References
Sriram K, Insel PA. G protein-coupled receptors as targets for approved drugs: how many targets and how many drugs? Mol Pharmacol. 2018;93:251–8.
Alexander SP, Davenport AP, Kelly E, Marrion N, Peters JA, et al. The concise guide to PHARMACOLOGY 2015/16: G protein-coupled receptors. Br J Pharmacol. 2015;172:5744–869.
Civelli O, Reinscheid RK, Zhang Y, Wang Z, Fredriksson R, Schioth HB. G protein-coupled receptor deorphanizations. Annu Rev Pharmacol Toxicol. 2013;53:127–46.
Sakmar TP, Menon ST, Marin EP, Awad ES. Rhodopsin: insights from recent structural studies. Annu Rev Biophys Biomol Struct. 2002;31:443–84.
Acknowledgments
The author acknowledges technical input by Benjamin Schoeder and Schengwei Wu. This work was supported by National Institutes of Health Grant R01 ES022966 (to S.C.M.).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
McKarns, S.C. (2022). Neuroreceptors. In: Bollu, P.C. (eds) Neurochemistry in Clinical Practice. Springer, Cham. https://doi.org/10.1007/978-3-031-07897-2_15
Download citation
DOI: https://doi.org/10.1007/978-3-031-07897-2_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-07896-5
Online ISBN: 978-3-031-07897-2
eBook Packages: MedicineMedicine (R0)